Complete Blood Count (CBC): What It Is, Why You May Need It, and How It Works

The complete blood count, or CBC, is one of the most common blood tests. It measures the different cells that make up your blood, including red blood cells, white blood cells, and platelets, and gives your provider a broad picture of your overall health.

The beta-galactosidase test measures how much of this enzyme is active in your white blood cells (leukocytes). Beta-galactosidase is an important enzyme that helps break down complex molecules called gangliosides. Without enough of this enzyme, these molecules can build up in cells and cause damage.

Your doctor may order a CBC as part of a routine checkup, before surgery, or to help investigate symptoms such as fatigue, weakness, fever, frequent bruising, or unexplained bleeding. It is also used to monitor an existing condition or how a treatment is working.

Your doctor may order this test if you or your child show symptoms of GM1 gangliosidosis, a rare genetic disorder. Symptoms can include developmental delays, movement problems, intellectual disability, enlargement of liver and spleen, and distinctive facial features. This test helps confirm whether beta-galactosidase deficiency is the cause of these symptoms.

The test is done with a simple blood draw. A health professional cleans your skin, places a band around your upper arm, and collects a small sample of blood from a vein, usually on the inside of your elbow. The sample is then sent to a laboratory for analysis.

A healthcare professional will draw a blood sample from a vein in your arm. The blood is then sent to a laboratory where specialists measure the activity of beta-galactosidase in the white blood cells. You may feel a brief sting when the needle is inserted, and there might be minor bruising afterward.

Your results show whether the numbers, sizes, and types of your blood cells fall within normal ranges. Values that are too high or too low may point to conditions such as anemia, infection, inflammation, dehydration, or clotting problems. Your provider will explain what your specific values mean for you.

Abnormally low beta-galactosidase activity typically indicates GM1 gangliosidosis. Your doctor will interpret your results along with your symptoms, medical history, and other test results. If the test confirms GM1 gangliosidosis, your healthcare team will discuss treatment options and management strategies with you.

This test is very safe. The most common effects are brief pain and mild bruising or soreness at the needle site. Rare risks include continued bleeding, infection, or feeling lightheaded or faint during or shortly after the blood draw.

The blood draw carries minimal risks, including slight pain, bruising, or bleeding at the puncture site. In rare cases, fainting or infection may occur. These risks are generally minor and temporary.